Dr. Jason Yi Zhou
Raphaël Wisniewski
Alex C. Sapir

Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Dr. Ken Powell
Nanna Lüneborg

Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).